BOOTHBAY FUND MANAGEMENT, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$557,000
+139.1%
20,619
+146.8%
0.01%
+133.3%
Q3 2021$233,000
-15.0%
8,355
-9.5%
0.01%
-33.3%
Q2 2021$274,000
-30.6%
9,228
-41.3%
0.01%
-62.5%
Q3 2020$395,000
-15.6%
15,718
-18.1%
0.02%
-25.0%
Q2 2020$468,000
+32.2%
19,180
-19.7%
0.03%
+10.3%
Q1 2020$354,000
-49.5%
23,900
-44.7%
0.03%
-52.5%
Q4 2019$701,000
+109.3%
43,200
+297.1%
0.06%
+52.5%
Q1 2018$335,00010,8780.04%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders